Sign in

CIK 0001490978

  • Large accelerated filer

Schrodinger, Inc.

Sign in to watch
Ticker
SDGR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954284541
Phone
+1 503-299-1150
Business address
1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
  1. 4 Grant or award Director acquired 5,997 shares (grant or award)
  2. 4 Grant or award Director acquired 5,997 shares (grant or award)
  3. 4 Grant or award Director acquired 5,997 shares (grant or award)
  4. 4 Grant or award Director acquired 1,499 shares (grant or award)
  5. 4 Grant or award Director acquired 5,997 shares (grant or award)
  6. 4 Grant or award Director acquired 5,997 shares (grant or award)
  7. 4 Grant or award Director acquired 5,997 shares (grant or award)
  8. 4 Grant or award Director acquired 5,997 shares (grant or award)
  9. 4 Grant or award Director acquired 5,997 shares (grant or award)
  10. 4 Grant or award See Remarks acquired 14,063 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award EVP & CFO acquired 9,375 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Planned sale President of R&D, Therapeutics sold 16,723 shares at an average $25.09 ($419,570)
  15. 4 Grant or award Director acquired 10,000 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Planned sale SVP & Controller sold 666 shares at $21.11 ($14,059)
  18. 4 Open-market sale EVP & CFO sold 5,491 shares at $21.76 ($119,484)
  19. 4 Grant or award President of R&D, Therapeutics acquired 15,625 shares (grant or award)
  20. 4 Grant or award President & CEO acquired 37,500 shares (grant or award)

Page 3 of 17 · 326 filings